Floatz logo

Epo

Hemorrhagic Stroke

Yonsei UniversityPhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Hemorrhagic Stroke cohort.

Asset / SponsorPhaseRating
Cerebrolysin
Cardinal Stefan Wyszynski University
Phase 4BB
Lipitor
Duan Chuanzhi
Phase 4BB
Esmolol
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase 4BB
compound solution of sodium chloride
University Hospital Heidelberg
Phase 2B
Inomax
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase 4B

View all 21 →

Same molecule, other indications

Epo is also rated in:

peritoneal neoplasmDormant
B
Indicative ·
57 / 100
View asset →
fallopian tube cancerDormant
CCC
Indicative ·
51 / 100
View asset →
Neurological DiseasesDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →